Interleukin-1β inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells

Journal of Vascular Surgery

Volumn 39, Issue 5, 2004, Pages 1091-1096

  Englesbe, Michael J ^a   Deou, Jessie ^a   Bourns, Brenda D ^a   Clowes, Alexander W ^a   Daum, Günter ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN; CYCLOOXYGENASE 2; INDOMETACIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLATELET DERIVED GROWTH FACTOR BB; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; PROSTAGLANDIN SYNTHASE; RECOMBINANT PROTEIN;

ANGIOPLASTY; ANIMAL CELL; AORTA MEDIA; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BABOON; BLOOD FLOW; BLOOD VESSEL INJURY; CELL MIGRATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; STENT; VEIN GRAFT; WESTERN BLOTTING; ANIMAL; AORTA; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; INTIMA; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; PAPIO; PATHOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BLOTTING, WESTERN; CELL MIGRATION INHIBITION; CELL MOVEMENT; HUMANS; INTERLEUKIN-1; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAPIO; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECOMBINANT PROTEINS; TUNICA INTIMA;

EID: 2342629250     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.01.041     Document Type: Article

References (31)

1. Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000;35:555-62.
2. Giese NA, Marijianowski MM, McCook O, Hancock A, Ramakrishnan V, Fretto LJ, et al. The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vasc Biol 1999;19:900-9.
3. Hart CE, Kraiss LW, Vergel S, Gilbertson D, Kenagy R, Kirkman T, et al. PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 1999;99:564-9.
4. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
5. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993;13:1218-26.
6. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-11.
7. Deguchi J, Namba T, Hamada H, Nakaoka T, Abe J, Sato O, et al. Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther 1999;6:956-65.
8. Yamasaki Y, Miyoshi K, Oda N, Watanabe M, Miyake H, Chan J, et al. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res 2001;88:630-6.
9. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-76.
10. Oemar BS. Is interleukin-1 beta a triggering factor for restenosis? Cardiovasc Res 1999;44:17-9.
11. Francis SE, Camp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A, et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001;86:336-40.
12. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000;36:2168-73.
13. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000;191:303-12.
14. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo: the role of platelet-derived growth factor. J Clin Invest 1996;97:769-76.
15. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000;102:1697-702.
16. Wang X, Romanic AM, Yue TL, Feuerstein GZ, Ohlstein EH. Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem Biophys Res Commun 2000;271:138-43.
17. Chamberlain J, Gunn J, Francis S, Holt C, Crossman D. Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries. Cardiovasc Res 1999;44:156-65.
18. Nathe TJ, Deou J, Walsh B, Bourns B, Clowes AW, Daum G. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. Arterioscler Thromb Vasc Biol 2002;22:1293-8.
19. Ross R, Kariya B. Morphogenesis of vascular smooth muscle cells in atherosclerosis and cell culture. In: Bohr D, editor. Handbook of physiology: the cardiovascular system II. Bethesda (MD): American Physiological Society; 1980. p 61-9.
20. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res 1994;75:682-91.
21. Jaccard J, Wan CK. LISREL approaches to interaction effects in multiple regression. Thousand Oaks (CA): Sage Publications; 1996.
22. Laporte JD, Moore PE, Lahiri T, Schwartzman IN, Panettieri RA Jr, Shore SA. p38 MAP kinase regulates IL-1 beta responses in cultured airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L932-41.
23. Beasley D. COX-2 and cytosolic PLA2 mediate IL-1beta-induced cAMP production in human vascular smooth muscle cells. Am J Physiol 1999;276(4 Pt 2):H1369-78.
24. Bishop-Bailey D, Burke-Gaffney A, Hellewell PG, Pepper JR, Mitchell JA. Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem Biophys Res Commun 1998;249:44-7.
25. Pang L, Knox AJ. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol 1997;121:579-87.
26. Yamaguchi H, Igarashi M, Hirata A, Tsuchiya H, Susa S, Tominaga M, et al. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells. Eur J Clin Invest 2001;31:672-80.
27. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 1998;439:75-80.
28. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am J Physiol 2002;282:C824-34.
29. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000;20:4265-74.
30. Connolly E, Bouchier-Hayes DJ, Kaye E, Leahy A, Fitzgerald D, Belton O. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. J Pharmacol Exp Ther 2002;300:393-8.
31. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, et al. Role of prostacyclin in the cardiovascular response to thromboxanwe A2. Science 2002;296:539-41.